3001 - 3050 of 6295 Results
Title
Year
- Composite measures of motor performance and self-efficacy are better determinants of postural instability and gait difficulties than individual clinical measures in Parkinson's disease2022OPENTitle: Composite measures of motor performance and self-efficacy are better determinants of postural instability and gait difficulties than individual clinical measures in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 107Issue #:Start Page: 105251End Page: 105251Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.105251Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10028594/pdf/nihms-1882881.pdfCitation Count: 4
- A novel approach to understanding Parkinsonian cognitive decline using minimum spanning trees, edge cutting, and magnetoencephalography2021OPENTitle: A novel approach to understanding Parkinsonian cognitive decline using minimum spanning trees, edge cutting, and magnetoencephalographyJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-99167-2Best OA location URL: https://www.nature.com/articles/s41598-021-99167-2.pdfCitation Count: 3
-
OPENTitle: mTOR hyperactivity mediates lysosomal dysfunction in Gaucher's disease iPSC-neuronal cellsJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 12Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.038596Best OA location URL: https://doi.org/10.1242/dmm.038596Citation Count: 60
- The Remote Assessment of Parkinsonism Supporting the Ongoing Development of Interventions in Gaucher Disease2021OPENTitle: The Remote Assessment of Parkinsonism Supporting the Ongoing Development of Interventions in Gaucher DiseaseJournal Name: Neurodegenerative Disease ManagementPublisher: Informa UK LimitedVol: 11Issue #: 6Start Page: 451End Page: 458Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.2217/nmt-2021-0032Best OA location URL: https://doi.org/10.2217/nmt-2021-0032Citation Count: 13
-
OPENTitle: Infrared nanoimaging of neuronal ultrastructure and nanoparticle interaction with cellsJournal Name: NanoscalePublisher: Royal Society of Chemistry (RSC)Vol: 16Issue #: 12Start Page: 6190End Page: 6198Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1039/d3nr04948eBest OA location URL: https://pubs.rsc.org/en/content/articlepdf/2024/nr/d3nr04948eCitation Count: 1
- A 12-month, dose-level blinded safety and efficacy study of levodopa inhalation powder (CVT-301, Inbrija) in patients with Parkinson's disease2020OPENTitle: A 12-month, dose-level blinded safety and efficacy study of levodopa inhalation powder (CVT-301, Inbrija) in patients with Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 81Issue #:Start Page: 144End Page: 150Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.10.029Best OA location URL: https://doi.org/10.1016/j.parkreldis.2020.10.029Citation Count: 19
- Longitudinal Assessment of Parkinson’s Motor Symptoms and Dopaminergic Dysfunction Patterns Using DaTSCAN2025OPENTitle: Longitudinal Assessment of Parkinson’s Motor Symptoms and Dopaminergic Dysfunction Patterns Using DaTSCANJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 12Issue #:Start Page: 100331End Page: 100331Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1016/j.prdoa.2025.100331Best OA location URL: https://doi.org/10.1016/j.prdoa.2025.100331Citation Count: 1
- Rapid eye movement sleep behavior disorder and rapid eye movement sleep without atonia are more frequent in advanced versus early Parkinson’s disease2021OPENTitle: Rapid eye movement sleep behavior disorder and rapid eye movement sleep without atonia are more frequent in advanced versus early Parkinson’s diseaseJournal Name: SleepPublisher: Oxford University Press (OUP)Vol: 44Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/sleep/zsab067Best OA location URL: https://academic.oup.com/sleep/article-pdf/44/9/zsab067/45297401/zsab067.pdfCitation Count: 24
-
OPENTitle: Prevalence of GBA p.K198E mutation in Colombian and Hispanic populationsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 73Issue #:Start Page: 16End Page: 18Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.03.008Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7528207Citation Count: 7
- Cortical volume abnormalities in posttraumatic stress disorder: an ENIGMA-psychiatric genomics consortium PTSD workgroup mega-analysis2020OPENTitle: Cortical volume abnormalities in posttraumatic stress disorder: an ENIGMA-psychiatric genomics consortium PTSD workgroup mega-analysisJournal Name: Molecular PsychiatryPublisher: Springer Science and Business Media LLCVol: 26Issue #: 8Start Page: 4331End Page: 4343Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41380-020-00967-1Best OA location URL: http://hdl.handle.net/1887/3280102Citation Count: 85
- Biochemical and neurophysiological effects of deficiency of the mitochondrial import protein TIMM502024OPENTitle: Biochemical and neurophysiological effects of deficiency of the mitochondrial import protein TIMM50Journal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.99914Best OA location URL: https://doi.org/10.7554/elife.99914Citation Count: 3
-
OPENTitle: Genetic architecture of subcortical brain structures in 38,851 individualsJournal Name: Nature GeneticsPublisher: Springer Science and Business Media LLCVol: 51Issue #: 11Start Page: 1624End Page: 1636Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41588-019-0511-yBest OA location URL: https://www.nature.com/articles/s41588-019-0511-y.pdfCitation Count: 261
- Small molecule C381 targets the lysosome to reduce inflammation and ameliorate disease in models of neurodegeneration2022OPENTitle: Small molecule C381 targets the lysosome to reduce inflammation and ameliorate disease in models of neurodegenerationJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 119Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2121609119Best OA location URL: https://escholarship.org/uc/item/4pt523rvCitation Count: 40
- R1441C and G2019S LRRK2 knockin mice have distinct striatal molecular, physiological, and behavioral alterations2022OPENTitle: R1441C and G2019S LRRK2 knockin mice have distinct striatal molecular, physiological, and behavioral alterationsJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s42003-022-04136-8Best OA location URL: https://www.nature.com/articles/s42003-022-04136-8.pdfCitation Count: 20
- Cohort-specific boolean models highlight different regulatory modules during Parkinson’s disease progression2024OPENTitle: Cohort-specific boolean models highlight different regulatory modules during Parkinson’s disease progressionJournal Name: iSciencePublisher: Elsevier BVVol: 27Issue #: 10Start Page: 110956End Page: 110956Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.isci.2024.110956Best OA location URL: https://doi.org/10.1016/j.isci.2024.110956Citation Count: 1
- Safety and Feasibility of Serial Lumbar Punctures: Long-term Results from the Parkinson’s Progression Markers Initiative2025OPENTitle: Safety and Feasibility of Serial Lumbar Punctures: Long-term Results from the Parkinson’s Progression Markers InitiativeJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 13Issue #:Start Page: 100385End Page: 100385Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2025.100385Best OA location URL: https://doi.org/10.1016/j.prdoa.2025.100385Citation Count: 0
-
OPENTitle: T-cell based immunotherapies for Parkinson’s diseaseJournal Name: Exploration of Neuroprotective TherapyPublisher: Open Exploration PublishingVol: 1Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.37349/ent.2021.00007Best OA location URL: https://www.explorationpub.com/uploads/Article/A10047/10047.pdfCitation Count: 11
-
OPENTitle: Potential Protective Link Between Type I Diabetes and Parkinson's Disease Risk and ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 7Start Page: 1350End Page: 1355Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29424Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29424Citation Count: 11
- Small RNA Changes in Plasma Have Potential for Early Diagnosis of Alzheimer’s Disease before Symptom Onset2024OPENTitle: Small RNA Changes in Plasma Have Potential for Early Diagnosis of Alzheimer’s Disease before Symptom OnsetJournal Name: CellsPublisher: MDPI AGVol: 13Issue #: 3Start Page: 207End Page: 207Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells13030207Best OA location URL: https://escholarship.org/uc/item/0t24p8d5Citation Count: 2
-
OPENTitle: Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD CohortJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 2Start Page: 286End Page: 303Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29288Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29288Citation Count: 38
-
OPENTitle: LRRK2 mediates haloperidol-induced changes in indirect pathway striatal projection neuronsJournal Name: Molecular PsychiatryPublisher: Springer Science and Business Media LLCVol: 30Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41380-025-03030-zBest OA location URL: https://doi.org/10.1038/s41380-025-03030-zCitation Count: 1
- Cysteine oxidation and redox signaling in dopaminergic neurons physiology and in Parkinson’s disease2019OPENTitle: Cysteine oxidation and redox signaling in dopaminergic neurons physiology and in Parkinson’s diseaseJournal Name: Current Opinion in PhysiologyPublisher: Elsevier BVVol: 9Issue #:Start Page: 73End Page: 78Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.cophys.2019.04.025Best OA location URL: https://ars.els-cdn.com/content/image/1-s2.0-S2468867319300859-fx1_lrg.jpgCitation Count: 9
- Exploring [11C]CPPC as a CSF1R-targeted PET imaging marker for early Parkinson’s disease severity2025OPENTitle: Exploring [11C]CPPC as a CSF1R-targeted PET imaging marker for early Parkinson’s disease severityJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 135Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1172/jci186591Best OA location URL: http://www.jci.org/articles/view/186591/files/pdfCitation Count: 2
-
OPENTitle: Rapid ex vivo reverse genetics identifies the essential determinants of prion protein toxicityJournal Name: Brain PathologyPublisher: WileyVol: 33Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/bpa.13130Best OA location URL: https://doi.org/10.1111/bpa.13130Citation Count: 4
-
OPENTitle: Team Science Approaches to Unravel Monogenic Parkinson's Disease on a Global ScaleJournal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 10Start Page: 1868End Page: 1873Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.29925Best OA location URL: https://doi.org/10.1002/mds.29925Citation Count: 5
-
OPENTitle: Cyclic Alternating Pattern Dynamics in Individuals at Risk for Developing Parkinson's DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 98Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.27217Citation Count: 1
- 4R-cembranoid protects neuronal cells from oxygen–glucose deprivation by modulating microglial cell activation2021OPENTitle: 4R-cembranoid protects neuronal cells from oxygen–glucose deprivation by modulating microglial cell activationJournal Name: Brain Research BulletinPublisher: Elsevier BVVol: 179Issue #:Start Page: 74End Page: 82Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainresbull.2021.12.007Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8849140Citation Count: 9
- Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells for Parkinson's Disease: A Randomized Trial2025OPENTitle: Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells for Parkinson's Disease: A Randomized TrialJournal Name: Movement DisordersPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.70028Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.70028Citation Count: 0
-
OPENTitle: Closing the structure-to-function gap for LRRK2Journal Name: Trends in Biochemical SciencesPublisher: Elsevier BVVol: 47Issue #: 3Start Page: 187End Page: 188Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.tibs.2021.10.003Best OA location URL: http://www.cell.com/article/S0968000421002243/pdfCitation Count: 8
- Common signatures of differential microRNA expression in Parkinson’s and Alzheimer’s disease brains2022OPENTitle: Common signatures of differential microRNA expression in Parkinson’s and Alzheimer’s disease brainsJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 4Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcac274Best OA location URL: https://academic.oup.com/braincomms/article-pdf/4/6/fcac274/46907691/fcac274.pdfCitation Count: 19
- Modeling and optimizing deep brain stimulation to enhance gait in Parkinson’s disease: personalized treatment with neurophysiological insights2025OPENTitle: Modeling and optimizing deep brain stimulation to enhance gait in Parkinson’s disease: personalized treatment with neurophysiological insightsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-00990-5Best OA location URL: https://www.nature.com/articles/s41531-025-00990-5.pdfCitation Count: 2
-
OPENTitle: Palliative Care and Parkinson's Disease: Time to Move Beyond CancerJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1325End Page: 1329Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28556Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8217287Citation Count: 22
-
OPENTitle: Early-stage idiopathic Parkinson’s disease is associated with reduced circular RNA expressionJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00636-yBest OA location URL: https://www.nature.com/articles/s41531-024-00636-y.pdfCitation Count: 12
-
OPEN
-
OPENTitle: Genome-wide evaluation of the effect of short tandem repeat variation on local DNA methylationJournal Name: Genome ResearchPublisher: Cold Spring Harbor LaboratoryVol: 33Issue #: 2Start Page: 184End Page: 196Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1101/gr.277057.122Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10069470Citation Count: 19
- Deficiency of the serine peptidase Kallikrein 6 does not affect the levels and the pathological accumulation of a‐synuclein in mouse brain2020OPENTitle: Deficiency of the serine peptidase Kallikrein 6 does not affect the levels and the pathological accumulation of a‐synuclein in mouse brainJournal Name: Journal of NeurochemistryPublisher: WileyVol: 157Issue #: 6Start Page: 2024End Page: 2038Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.15199Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.15199Citation Count: 7
-
OPENTitle: A Molecular Tweezer Ameliorates Motor Deficits in Mice Overexpressing α-SynucleinJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 14Issue #: 4Start Page: 1107End Page: 1119Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1007/s13311-017-0544-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-017-0544-9.pdfCitation Count: 54
- Correlation between orphan nuclear receptor Nurr1 expression and amyloid deposition in 5XFADmice, an animal model of Alzheimer's disease2014OPENTitle: Correlation between orphan nuclear receptor Nurr1 expression and amyloid deposition in 5XFADmice, an animal model of Alzheimer's diseaseJournal Name: Journal of NeurochemistryPublisher: WileyVol: 132Issue #: 2Start Page: 254End Page: 262Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.12935Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.12935Citation Count: 42
-
OPENTitle: Regulation of Memory Formation by the Transcription Factor XBP1Journal Name: Cell ReportsPublisher: Elsevier BVVol: 14Issue #: 6Start Page: 1382End Page: 1394Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2016.01.028Best OA location URL: https://doi.org/10.1016/j.celrep.2016.01.028Citation Count: 157
-
OPENTitle: Abundant non-inclusion α-synuclein pathology in Lewy body-negative LRRK2-mutant casesJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 149Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-025-02871-wBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-025-02871-w.pdfCitation Count: 9
-
OPENTitle: Dual Tasking for the Differentiation between Depression and Mild Cognitive ImpairmentJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2016.00235Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2016.00235/pdfCitation Count: 20
-
OPENTitle: Genetic Modifiers of Parkinson's Disease: A Case–Control StudyJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.70176Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.70176Citation Count: 0
-
OPENTitle: Mining the neuroimaging literatureJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.94909.2Best OA location URL: https://doi.org/10.7554/elife.94909.2Citation Count: 0
-
OPENTitle: Harmonization of Structural Brain Connectivity Through Distribution MatchingJournal Name: Human Brain MappingPublisher: WileyVol: 46Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/hbm.70257Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hbm.70257Citation Count: 0
- Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study2018OPENTitle: Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 17Issue #: 6Start Page: 548End Page: 558Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(18)30126-1Best OA location URL: https://pure.au.dk/portal/en/publications/5858439f-d412-4c8f-a441-be42b07b0f77Citation Count: 115
-
OPENTitle: Parkinson’S Disease is Ready for Precision MedicineJournal Name: Personalized MedicinePublisher: Informa UK LimitedVol: 13Issue #: 5Start Page: 405End Page: 407Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2217/pme-2016-0052Best OA location URL: https://www.futuremedicine.com/doi/pdf/10.2217/pme-2016-0052Citation Count: 7
- The angiotensin (1–7) glycopeptide PNA5 improves cognition in a chronic progressive mouse model of Parkinson's disease through modulation of neuroinflammation2024OPENTitle: The angiotensin (1–7) glycopeptide PNA5 improves cognition in a chronic progressive mouse model of Parkinson's disease through modulation of neuroinflammationJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 381Issue #:Start Page: 114926End Page: 114926Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.expneurol.2024.114926Citation Count: 5
- Activation of FADD-Dependent Neuronal Death Pathways as a Predictor of Pathogenicity for LRRK2 Mutations2016OPENTitle: Activation of FADD-Dependent Neuronal Death Pathways as a Predictor of Pathogenicity for LRRK2 MutationsJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 11Issue #: 11Start Page: e0166053End Page: e0166053Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0166053Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0166053&type=printableCitation Count: 18
- Quantitative proteomics identifies altered O‐GlcNAcylation of structural, synaptic and memory‐associated proteins in Alzheimer's disease2017OPENTitle: Quantitative proteomics identifies altered O‐GlcNAcylation of structural, synaptic and memory‐associated proteins in Alzheimer's diseaseJournal Name: The Journal of PathologyPublisher: WileyVol: 243Issue #: 1Start Page: 78End Page: 88Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/path.4929Best OA location URL: http://doi.org/10.1002/path.4929Citation Count: 127
- Increased brain expression of GPNMB is associated with genome wide significant risk for Parkinson’s disease on chromosome 7p15.32017OPENTitle: Increased brain expression of GPNMB is associated with genome wide significant risk for Parkinson’s disease on chromosome 7p15.3Journal Name: neurogeneticsPublisher: Springer Science and Business Media LLCVol: 18Issue #: 3Start Page: 121End Page: 133Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s10048-017-0514-8Best OA location URL: https://link.springer.com/content/pdf/10.1007%2Fs10048-017-0514-8.pdfCitation Count: 70